The Prognostic and Predictive Value of Genomic Assays in Guiding Adjuvant Breast Radiation Therapy

Many patients with non-metastatic breast cancer benefit from adjuvant radiation therapy after lumpectomy or mastectomy on the basis of many randomized trials. However, there are many patients that have such low risks of recurrence after surgery that de-intensification of therapy by either reducing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyer, Sasha J., Tallman, Miranda, Jhawar, Sachin R., White, Julia R., Bazan, Jose G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855532/
https://www.ncbi.nlm.nih.gov/pubmed/36672606
http://dx.doi.org/10.3390/biomedicines11010098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855532/
https://www.ncbi.nlm.nih.gov/pubmed/36672606
http://dx.doi.org/10.3390/biomedicines11010098

Ejemplares similares